glp-1 agonist or antagonist GIPR/GLP-1R dual therapies for diabetes and weight loss—chemistry, physiology, and clinical applications GLP-1 Receptor Agonists as Treatments

10.1155/2018/4315413 Int J Endocrinol

Intestinal permeation enhancers for oral delivery of macromolecules: a comparison between salcaprozate sodium (SNAC) and sodium caprate (C(10))

Overall, current guidelines recognize liraglutide and semaglutide as first-line pharmacotherapy options for severe adolescent obesity when combined with lifestyle therapy

This content cannot be viewed by non-subscribers/non-members.

So we rolled up our sleeves and dug into the actual science

GLP-1 Receptor Agonists: Mascots & Mnemonics Jason Cafer MD Oct 17, 2021 10 min read Updated: Jan 29, 2023 Glucagon-like peptide-1 (GLP-1) receptor agonists, the -tides GLP-1 receptor agonists are type 2 diabetes medications, also called GLP analogs or incretin mimetics